AGTC gets orphan designation in the EC for XLRP gene therapy
8 June 2016 | By Victoria White, Digital Content Producer
The orphan medicinal product designation was granted to AGTC's investigational gene therapy for the treatment XLRP caused by mutations in the RPGR gene...